Biopsy Guidance System Market is projected to reach US$ 2 Billion by 2032 at a CAGR of 5.8%

The global Biopsy Guidance System Market is anticipated to create an opulent growth outlook of the market over the assessment period by registering a CAGR of 5.8% from 2022 to 2032. The global market was valued at US$ 1.1 Billion in 2021 and is expected to surpass a valuation of US$ 2 Billion by 2032. …

Rare NGR1 Fusion Market is likely to reach US$ 20 Billion by 2033, with a CAGR of 7.73%

The global Rare NGR1 Fusion Market is estimated to achieve an amazing valuation of US$ 9.49 billion in 2023 and reach US$ 20 billion by 2033, with a CAGR of 7.73%. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Rare NGR1 Fusion market. FMI offers insights into …

Primary Sclerosing Cholangitis (PSC) Market is projected to grow at a CAGR of 7.6%, totaling around US$ 314.26 Million by 2033

The global Primary Sclerosing Cholangitis (PSC) Market is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis (PSC) …

Amyotrophic Lateral Sclerosis is expected to accumulate a market value of US$ 1332.22 Million by registering a CAGR of 6% 2023 to 2033

The global Amyotrophic Lateral Sclerosis Market is estimated to generate a market value of US$ 743.90 Million in 2023 and a market value of US$ 1332.22 Million by achieving a CAGR of 6% between 2023 and 2033. Amyotrophic Lateral Sclerosis market growth can be attributable to an aging population, increased awareness of ALS, and an increasing incidence rate. Amyotrophic Lateral Sclerosis (ALS) market …

Drug-Induced Dyskinesia Market is expected to grow at a steady 4.25% CAGR, reaching a value of US$ 620.2 Million by 2033

In the year 2022, the global Drug-Induced Dyskinesia Market was estimated to be worth US$ 382 Million. Considering the rising demand in the global market, it is predicted to reach a valuation of US$ 399.8 Million by 2023. The market will also exhibit a steady CAGR of 4.25% from 2023-2033 and hence ultimately reach US$ 620.2 Million …

Non-Small Cell Lung Cancer is expected to accumulate a market value of US$ 20 Billion by registering a CAGR of 7.2% 2023 to 2033

A recently published study by FMI expects the global Non-Small Cell Lung Cancer Market to augment at a 7.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 20 Billion is expected for the market. From 2018 to 2022, the industry experienced noteworthy growth, registering a value CAGR of …

Swine Vaccine Market is projected to grow at a CAGR of 5.8% from 2022 to 2032

According to Future Market Insights’ newly released Global Swine Vaccine Market analysis report, the global market for Swine Vaccine was valued at over US$ 1.5 billion in 2021, and is expected to rise at a CAGR of 5.8% from 2022 to 2032. With an absolute dollar opportunity of US$ 1.2 billion, the market is likely …

Legionnaire Disease Testing Market is predicted to register a CAGR of 9% from 2022 to 2032

The legionnaire disease testing market is projected to register a CAGR of 9% during the forecast period, up from US$ 292 Mn in 2022 to reach a valuation of US$ 819.5 Mn by 2032. A severe form of pneumonia infection is known as legionnaire disease which causes lung inflammation. The bacteria are known as legionella cause legionnaire disease. The …

Dental Floss Market is expected to register a CAGR of 8% for the forecast period 2022 to 2032

[Report of 300 Pages] The global dental floss market is expected to generate a market value of US$ 626.41 Million in 2022 and a CAGR of 8% from 2022 to 2032, accumulating a market value of US$ 1.35 Billion in 2032. The market’s expansion can be attributed to rising awareness of dental hygiene and oral health. Dental …

Intubation Tube Market is projected to grow at a CAGR of over 7.2% from 2022 to 2032

The Intubation Tube Market revenues were estimated at US$ 2.2 Bn in 2021 and is anticipated to grow at a CAGR of 6.8% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 4.5 Bn. Market revenue through regular Intubation Tube …